Lectures by Invitation

9/13/2023	Humanitas university, Milan. The complement system at the forefront of novel immunotherapies.
6/2/2023	18th International Conference on Innate Immunity, Chania, Greece. The dawn of clinical C3 inhibition: the story, its milestones and what lies ahead.
5/27/2023	15th International Conference on Complement Therapeutics, Chania, Greece.The dawn of clinical C3 inhibition: the story, its milestones and what lies ahead.
6/23/2022	14th International Conference on Complement Therapeutics. Rhodes Greece. Taking C3 inhibition to the next level: new insights and clinical opportunities.
10/21/2021	Penn Dental Medicine-Frontiers in Science. C3-targeted therapy in periodontal disease: moving closer to the clinic.
9/9/2021	13th International Conference on Complement Therapeutics, Ioannina, Greece. Clinical development of the compstatin-based C3 therapeutic AMY-101 as a novel host modulation therapy for periodontal inflammation.
5/14/2021	200 years of the Greek World and Neurosciences. Complement Therapeutics: Missconceptions, Myths and novel Insights.
12/12/2020	100th Anniversary of Jules Bordet's Nobel Prize, Royal Academy of Medicine of Belgium. The complement system at the forefront of novel immunotherapies. YouTube
12/10/2020	7th Panhellenic e-Congress of the Hellenic Academy of Neuroimmunology. Plenary Lecture: Targeting the complement system. Video
6/24/2019	13th International Conference on Pathways, Networks, and Systems Medicine, Chania, Crete, Greece. An update on the clinical development of compstatin-based drug candidate AMY-101.
6/13/2019	12th International Conference on Complement Therapeutics, Rhodes, Greece. An update on the clinical development of the compstatin-based drug candidate AMY-101.
5/17/2019	The New Era of Aplastic Anemia and Paroxysmal Noctrunal Hemoglobinuria, Napoli, Italy. Anti-C3: AMY-101 and other compstatins.
8/29/2018	University Hospital, University of Sao Paulo, Ribeirao Preto, Brazil. Innate immunity: More than a guard against invading pathogens.
8/28/2018	Butantan Institute, Sao Paulo, Brazil. Innate immunity: More than a guard against invading pathogens.
7/24/2018	11th International Conference on Complement Therapeutics, Chania, Crete, Greece. An update on the clinical development of compstatin (AMY-101).
3/10/2018	University of Athens Medical School, Department of Pathology-Nephrology. Complement therapeutics.
9/11/2017	University of Malmo, Malmo, Sweden. Development of pharmacological interventions against complement factor C3 and potential indications in renal medicine and transplantation.
9/8/2017	C3G Satellite Meeting, Copenhagen, Denmark. Targeting C3.
9/6/2017	University of Ulm, Ulm, Germany. News in the world of complement research.
6/30/2017	12th International Conference on Pathways, Networks, and Systems Medicine, Heraklion, Crete, Greece. Status of complement therapeutics.
6/27/2017	10th International Conference on Complement Therapeutics. Compstatin Cp40 (AMY101): A C3 complement inhibitor reaching its prime for bedside intervention, Heraklion, Crete, Greece.
6/21/2017	14th International Conference on Innate Immunity, Heraklion, Crete, Greece. Therapeutic complement inhibition at the level of C3: microconceptions, myths, and novel insight.
9/30/2016	2nd International Conference on Immune Responses to Biosurfaces: Mechanisms and Therapeutic Interventions, Ixia, Rhodes, Greece. Compstatin Cp40 (AMY-101): A C3 targeted complement inhibitor reaching its prime for bedside intervention.
6/29/2016	9th International Conference on Complement Therapeutics, Ixia, Rhodes, Greece. Compstatin Cp40 (AMY-101): A C3 targeted complement inhibitor reaching its prime for bedside intervention.
6/25/2016	13th International Conference on Innate Immunity, Ixia, Rhodes, Greece. Compastatin Cp40 (AMY-101): A C3 targeted complement inhibitor reaching its prime for bedside intervention.
11/18/2015	IPITA, IXA, CTS Joint Congress, Melbourne, Australia. New reagents to regulate complement activation.
9/2/2015	8th International Conference on Complement Therapeutics, Chania, Crete, Greece. An update on the preclinical and clinical development of the therapeutic C3 inhibitor Cp40.
8/11/2015	12th World Congress on Inflammation, Boston, MA, USA. Compstatin CP40: An immune modulator on a journey from disease models to clinical development.
8/9/2015	12th World Congress on Inflammation, Boston, MA, USA. Complement: More than a "guard" against pathogens.
6/21/2015	12th International Conference on Innate Immunity, Chania, Crete, Greece. Compstatin Cp40: An immune modulator on a journey from disease models to clinical development.
5/3/2015	State of the Art Speaker, American Transplantation Conference, Philadelphia, PA, USA. Complement: More Than a "guard" against pathogens.
1/9/2015	University of Florence, Italy. Complement: More than a "guard" against pathogens.
9/29/2014	1st International Conference on Immune Responses to Biosurfaces: Mechanisms and Therapeutic Interventions, Chania, Crete, Greece. Cp40: A complement inhibitor getting ready for primetime.
6/5/2014	11th International Conference on Innate Immunity, Olympia, Greece. Complement C3 ihibitors getting ready for primetime: Compstatin Cp40 in local and systemic applications.
5/22/2014	Linneaus University Center for Biomaterials Chemistry, Kalmar, Sweden. Therapeutic complement inhibition at the level of C3: microconceptions, myths, and novel insight.
4/9/2014	Institute for Systemic Inflammation Research, Luebeck University, Luebeck, Germany. Innate immunity: More than a guard against invading pathogens.
3/27/2014	Aplastic Anemia & MDS International Foundation. Bone Marrow Failure Disease Scientific Symposium, Rockville, MD. Rational and preclinical development of novel strategy of complement inhibition.
8/25/2013	15th International Congress of Immunology, Milan, Italy. The renaissance of complement.
6/27/2013	10th International Conference on Innate Immunity, Kos, Greece. Preclinical development of compstatin: Progress, applications, and insight about therapeutic complement inhibition at the level of C3.
6/19/2013	6th International Conference on Complement Therapeutics, Kos, Greece. Therapeutic complement inhibition at the level of C3: Microconceptions, myths, and novel insight.
1/24/2013	Rudbeck Seminar, Uppsala University, Sweden. Innate immunity: More than a guard against invading pathogens.
1/18/2013	15th Rheumatology Scientific Meeting of the Northwestern Greece, Ioannina, Greece. Innate immunity: More than a "guard" against pathogens.
1/17/2013	Medical and Dental Societies, Agrinion, Greece. Microbes: Friends or Foes?
1/16/2013	EKFE, Arta, Greece. Microbes: Friends or Foes?
1/12/2013	Balances: Basic Knowledge and Development in Hematology, Ioannina, Greece. Innate Immunity: Therapeutic approaches with emphasis on hematological diseases.
10/13/2012	XXIV International Complement Workshop, Chania, Crete, Greece. Bringing compstatin to the next level: Novel analogs with improved potency, pharmacokinetic profiles and administration options suitable for systemic application.
10/8/2012	Tumor Microenvironment and Cellular Stress: Signaling, Metabolism, Imaging and Therapeutic Targets, Chania, Crete, Greece. Shifting a paradigm? Unexpected functions of complement in cancer.
6/26/2012	9th International Conference on Innate Immunity, Rhodes, Greece. Compstatin: A complement inhibitor on its way to clinical application.
6/8/2012	13th Naples Workshop on Bioactive Peptides, Naples, Italy. Peptide based complement inhibitors: From bench to bedside.
2/21/2012	Sanquin Blood Supply Foundation, Dept. of Immunopathology, Amsterdam, The Netherlands. Innate immunity: More than a "guard" against invading pathogens.
11/8/2011	State of the Art lecture, ACR/ARHP Annual Scientific Meeting, Chicago. Complementary roles for complement in rheumatic diseases.
10/26/2011	Dept. di Biochimica e Biotecnologie Mediche, Dept. Assistenziale di Clinica Medica, Universita di Napoli Federico II. Innate immunity: More than a "guard" against invading pathogens.
10/25/2011	Instituto di Biostrutture e Bioimmagini, Consiglio Nazionale delle Ricerche, Naples, Italy. Structure and function of complement proteins and design of complement inhibitors.
10/21/2011	Department of Medicine, Division of Allergy and Immunology, University of Pennsylvania. Innate immunity: More than a "guard" against invading pathogens.
10/6/2011	Department of Ophthalmology, University of Pennsylvania. Innate immunity: More than a "guard" against invading pathogens.
10/5/2011	Center for Research on Reproduction and Women's Health, University of Pennsylvania Perelman School of Medicine. Innate immunity: More than a "guard" against invading pathogens.
9/14/2011	4th International Conference on Crossroads between Innate and Adaptive Immunity, Mykonos, Greece. A keystone biological system for immune surveillance and homeostasis.
6/23/2011	5th International Complement Therapeutics Conference, Rhodes, Greece. An update on compstatin.
6/17/2011	8th International Innate Immunity Workshop, Crete, Greece. Innate immunity: More than a "guard" against invading pathogens.
6/14/2011	9th International Conference on Pathways, Networks and Systems Medicine, Crete, Greece. Innate immunity: More than a "guard" against invading pathogens.
4/8/2011	City University of Hong Kong. Innate immunity: More than a "guard" against invading pathogens.
3/4/2011	Systems Biology Institute, Seattle. Innate immunity: More than a "guard" against invading pathogens.
1/19/2011	The University of Chicago, Committee on Microbiology Seminar Series. The renaissance of complement.
12/2/2010	Department of Molecular Microbiology and Immunology, Brown University. The renaissance of complement.
10/2/2010	1st Biennial Symposium on AMD, Harvard Medical School, Boston. Complement therapeutics.
9/16/2010	Somalogic, Boulder, Colorado. A "multidisciplinary" approach to understand disease and pathogenesis and develop therapeutics.
3/29/2010	3rd Joint Conference of the German Society for Hygiene and Microbiology (DGHM) e.V. and the Association for General and Applied Microbiology (VAAM), Hanover, Germany. The renaissance of complement.
11/28/2009	1st International Conference on Molecular Cancer Research, Athens, Greece. Shifting the paradigm. Unexpected functions of complement in cancer.
11/27/2009	National Academy of Athens, Greece. Innate immunity.
11/11/2009	University of Michigan, Department of Pathology. The renaissance of complement.
10/27/2008	Department of Pathology and Laboratory Medicine, University of Pennsylvania. System biology approaches to disease pathogenesis and development of therapeutics.
1/18/2008	Division of Allergy and Immunology, University of Pennsylvania. Complement therapeutics.
10/26/2007	Durham, NC. 1st Annual DIRECT Dry AMD Meeting. Complement biology and biochemistry.
10/19/2007	Department of Neurology Thomas Jefferson University. Systems approaches to disease pathogenesis and development of therapeutics.
9/25/2007	Department of Crystal and Structural Chemistry, Bijvoet Centre for Bimolecular Research, Utrecht University. The structures and functions of the complement system.
6/24/2007	5th International Conferences on Pathways, Networks, and Systems: Theory and Experiments, Porto Heli, Greece. Systems approaches to disease pathogenesis and development of therapeutics.
6/13/2007	4th Workshop on Complement Associated Diseases, Animal Models, and Therapeutics,Porto Heli, Greece. Novel complement therapeutics.
6/5/2007	4th International Leukocyte Signal Transduction Workshop: Clinical implications of signaling pathways, Rhodes, Greece. Systems approaches to disease pathogenesis and development of therapeutics.
4/23/2007	2nd Biosciences Congress, University of Patras, Greece. Plenary lecture on "The today’s challenges in biosciences."
4/19/2007	41st Annual Scientific Meeting of the European Society for Clinical Investigation, Uppsala, Sweden. Interference with complement activation.
2/6/2007	Stem Cell Biology Program, James Graham Brown Cancer Center University of Louisville. From atoms to systems: A "multidisciplinary" approach to today’s challenges in biosciences.
12/7/2006	Division of Cell Biology and Biophysics, University of Missouri-Kansas City. From atoms to systems: A "multidisciplinary" approach to today’s challenges in biosciences.
12/5/2006	GTCBio’s - Medicinal Chemistry at the 2nd Modern Drug Discovery & Development, Philadelphia, PA. Complement inhibitors: From bench to bedside.
10/17/2006	4th International Conferences on Pathways, Networks, and Systems: Theory and Experiments, Mykonos, Greece. A "multidisciplinary" approach to understand disease pathogenesis and develop therapeutics.
6/30/2006	1st International Conference on Ovarian Cancer: State of the Art and Future Directions, Crete, Greece. From atoms to systems: A "multidisciplinary" approach to understand disease pathogenesis and develop therapeutics.
6/7/2006	4th Innate Immunity Conference, Corfu, Greece. Protein-protein interactions in the complement system and development of complement therapeutics.
5/11/2006	University of Kalmar, Sweden. The today’s challenges in biosciences.
5/8/2006	Department of Clinical Immunology, University of Uppsala, Sweden. A "multidisciplinary" approach to today’s challenges in biosciences.
3/15/2006	Department of Chemical Engineering and Materials Science, University of Minnesota. Rational design of complement therapeutics.
10/11/2005	Grossroads between Innate and Adaptive Immunity, Rhodes, Greece. Integrating innate immunity into a "systems context"; The complement paradigm.
10/4/2005	3rd International Conference on Pathways, Networks and Systems: Theory and Experiments, Rhodes, Greece. Integrating innate immunity into a "systems context"; The complement paradigm.
9/10/2005	13th Signal and Signal Processing in the Immune System. EFIS Conference, Balatonöszöd, Hungary. From atoms to systems: A "multidisciplinary" approach to today’s challenges in biosciences.
6/7/2005	3rd Workshop on Complement Associated Diseases, Animal Models, and Therapeutics, Rhodes, Greece. From atoms to systems: A "multidisciplinary" approach to today’s challenges in biosciences.
5/31/2005	3rd Lymphocyte Signal Transduction Workshop, Crete, Greece. From atoms to systems: A "multidisciplinary" approach to today’s challenges in biosciences.
5/25/2005	2nd International Conference on Tissue Engineering, Crete, Greece. From atoms to systems: A "multidisciplinary" approach to today’s challenges in biosciences.
5/20/2005	BIOMED Seminar, Engineering School Drexel University. From atoms to systems: A "multidisciplinary" approach to today’s challenges in biosciences.
5/12/2005	FOCIS, Boston, MA. A multidisciplinary approach to complement functions.
3/17/2005	Philadelphia's Science Center. From atoms to systems: A multidisciplinary approach to today's challenges in biosciences.
3/9/2005	Department of Immunology, Beijing Medical School, China. From atoms to systems: A multidisciplinary approach to today's challenges in biosciences.
1/31/2005	Computer Science Department, School of Computer Science, Carnegie Mellon. From atoms to systems: A multidisciplinary approach to today’s challenges in Biosciences.
12/21/2004	Department of Pathology, University of Michigan. A multidisciplinary approach to today’s challenges in biosciences.
12/15/2004	Department of Pathology, School of Dental Medicine, University of Pennsylvania. A "cross-disciplinary" approach to complement mediated functions.
12/12/2004	Department of Pathology, Columbia University. Complement: More than a "guard" against invading pathogens.
9/10/2004	FEBS Immunology Summer Course, Killini, Greece. Complement: More than a "guard" against invading pathogens.
7/14/2004	Foundations of Computer Aided Process Design (FOCAPD): Design through product and process design. De novo protein design: An interplay of global optimization, mixed-integer optimization and experiments.
5/3/2004	Department of Genetics, Case Western Reserve University, Cleveland, OH. A "multidisciplinary" approach to today’s challenges in biosciences.
4/28/2004	Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison. A "multidisciplinary' approach to complement mediated functions.
4/22/2004	4th Orthopoxvirus Meeting, Washington DC. Vaccinia-host interactions.
3/2/2004	Enrique E. Ecker Memorial Lecture, Case Western Reserve University, Cleveland, OH. From atoms to systems: A "cross-disciplinary" approach to complement mediated functions.
1/22/2004	PENN center for Clinical Immunology, Seminars in Human Translational Immunology. Complement inhibitors: From bench to bedside.
12/8/2003	Department of Pathology, University of Pennsylvania. From atoms to systems: A "metadisciplinary" approach to innate immunity.
12/4/2003	NIH/NIEHS Science Retreat on Comparative Systems Biology Approaches as Applied to Environmental Health. A systems biology analysis of innate immunity.
11/28/2003	Departments of Biotechnology/Chemistry/Pharmacology, University of Modena, Italy. From atoms to systems: A "metadisciplinary" approach to innate immunity.
11/24/2003	Division of Rheumatology, University of Pennsylvania. A systems biology analysis of innate immunity.
10/21/2003	SOL Sherry Thrombosis Research Center, Temple University. A systems biology analysis of innate immunity.
9/30/2003	Aegean Conferences on Pathways, Networks, and Systems: Theory and Experiments, Santorini, Greece. A systems biology analysis of complement functions.
9/16/2003	South Jersey ACS Meeting. Rational design of complement inhibitors.
9/9/2003	Biochemical Society Focused Meeting, Stevenage, UK. Design of inhibitors for proteolytic cascades. Rational design of complement inhibitors.
8/3/2003	Baoding High Tech Developing Zone, China. Design of complement inhibitors.
6/10/2003	15th European Immunology Congress, Rhodes, Greece. Plenary lecture on Complement: More than a "guard" against invading pathogens.
2/17/2003	Department of Immunology, Beijing Medical School, China. Innate immunity: More than a "guard" against invading pathogens.
2/17/2003	University of Patras, Patras, Greece. Design of complement inhibitors.
2/12/2003	University of Ioannina, Ioannina, Greece. Post genomic era challenges.
12/10/2002	Microbiology and Immunology Distinguished Lecture Series, University of Texas Medical Branch, Galveston, TX. Innate immunity: More than a "guard" against invading pathogens.
11/13/2002	Exton, PA, 3-Dimentional Pharmaceuticals. Rational design of complement inhibitors.
6/17/2002	67th Meeting of British Biochemical Society, Cardiff, UK. Rational design of complement inhibitors.
3/27/2002	Department of Microbiology and Immunology, MCP-Drexel. Complement: More than a “guard” against invading pathogens.
10/11/2001	International Workshop on Complement Associated Diseases, Animal Models, and Therapeutics, Santorini, Greece. Design of complement therapeutics.
10/10/2001	International Workshop on Complement Associated Diseases, Animal Models, and Therapeutics, Santorini, Greece. The role of complement in developmental processes.
10/1/2001	Perspectives in Tunicate Biology- IV Anton Dohrn Workshop, Ischia, Italy. The role of complement in developmental processes.
6/22/2001	The 5th Nordic Symposium on Fish Immunology, Sundvollen, Norway. Structure and functions of trout complement proteins.
2/20/2001	Instituto Tecnologie Biomedichemie, CNR, Rome Italy. Therapeutic interventions in the complement system.
2/16/2001	Stazione Zoologica, Napoli, Italy. The diversity and evolution of innate immunity.
2/2/2001	Immunology Lecture series, Cornell University, Veterinary School, Ithaca, NY. Complement: New horizon.
1/12/2001	ICOS Corporation, Bothell, WA. Protein-protein interactions in the complement system and design of complement inhibitors.
12/6/2000	Pathology Lecture Series. University of Wisconsin-Madison. Protein-protein interactions in the complement system and design of complement inhibitors.
7/10/2000	St. George Hospital, Department of Immunology, Allergy & Infectious Diseases, University of New South Wales, Australia. Therapeutic potential of compstatin.
10/25/1999	EU Advanced Workshop in Biotechnology- Genome Sequence and Comparative Analysis, Thessaloniki, Greece. High throughput protein analysis: Proteomics and combinatorial chemistry.
10/4/1999	Pharmacology Seminar, Dep. of Pharmacology, Univ. of Pennsylvania, PA. Therapeutic potential of compstatin: A novel complement inhibitor isolated from a phage library.
7/15/1999	FASEB Summer Research Conference on Phylogenetic Perspectives on the Vertebrate Immune System. Complement phylogeny and diversity.
4/1/1999	Millennium Biotherapeutics, Boston. Therapeutic potential of compstatin.
11/11/1998	Marine Biotechnology Center, University of Maryland Special, Baltimore. Complement diversity.
11/3/1998	Division of Hematology & Oncology, CHOP, Philadelphia, PA. Inhibition of complement and cellular activation in whole blood in extracorporeal circulation by Compstatin.
5/23/1998	Special Symposium on Biotechology – Athens Greece. The use of combinatorial libraries in the drug discovery process.
5/13/1998	University of Ioannina, Greece. The use of combinatorial libraries in the drug discovery process.
5/7/1998	24th Panhellenic Medical Congress, Athens-Greece. The future xenotransplant.
12/4/1997	University of Thessaloniki, Greece. Therapeutic potential of Compstatin; a novel complement inhibitor.
12/2/1997	University of Patras, Greece. Therapeutic potential of Compstatin; a novel complement inhibitor.
11/12/1997	University of Oslo, Norway. Therapeutic potential of Compstatin; a novel complement inhibitor.
10/16/1997	IBC’s 3rd Annual Meeting, Washington D.C. Controlling the complement system. Complement inhibitor interfering with C3-ligand interactions.
5/2/1997	Institute of Molecular Medicine, UTC, Huston, TX. Complement and viral molecular mimicry.
10/18/1996	SangStat, Menlo Park, CA. A novel complement inhibitor isolated from a 7 phage-displayed random peptide library.
5/24/1996	Amgen Corporation, Boulder, Co. Protein-protein interactions in the complement system and viral molecular mimicry.
5/23/1996	University of Colorado, Department of Medicine, Denver, Co. Protein-protein interactions in the complement system and viral molecular mimicry.
10/26/1995	Children’s Hospital of Philadelphia, Division of Pulmonary Medicine. Molecular interactions in the complement system and viral molecular mimicry.
3/23/1995	Aristotelian University of Thessaloniki, Department of Pharmacology, Greece. Protein-protein interactions in the complement system and viral molecular mimicry.
3/21/1995	Institute Pasteur, Athens, Greece. Protein-protein interactions in the complement system and viral molecular mimicry.
3/20/1995	University of Patras, Department of Microbiology. Protein-protein interactions in the complement system and viral molecular mimicry.
12/7/1994	Umea University-Sweden, Medical School. Evasion strategies of microorganisms.
2/8/1994	University of Louisville, Department of Microbiology & Immunology. Structure, functioning and evolution of the third component of complement.
1/19/1994	Chiron Co., Emeryville, CA. Critical Care Seminar Series. Design of complement inhibitors.
11/11/1993	Alexion Co., New Haven, CT. Protein-protein interactions in the complement system and design of complement inhibitors.
5/24/1993	AAI Meeting, Denver, Co. Phylogenetic analysis of C3.
3/9/1993	Temple University, Department of Microbiology & Immunology. Protein-protein interactions in the complement system.
2/3/1993	University of Pennsylvania, Research Center in Oral Medicine. Protein-protein interactions in the complement system.
12/3/1992	Umea University-Sweden, Medical School. Protein-protein interactions in the complement system.
10/24/1992	Fourth International Conference of Anticancer Research, Crete, Greece. Structure and functions of EBV/C3 receptors on human T lymphocytes.
6/5/1992	Washington University (Howard Hughes Scholar), Howard Hughes Medical Institute. Protein-protein interactions in the complement system.
5/16/1992	University of Patras, Department of Microbiology. Evasion Strategies of Microorganisms.
5/14/1992	Second World Conference of the Hellenic Bio-medical Diaspora, Athens, Greece. Structure, functions and phylogeny of C3.
5/11/1992	University of Pennsylvania, Division of Laboratory Medicine. Structure and functions of complement proteins.
8/28/1991	25 Years of Biology in Patras, University of Patras, Department of Biology, Symposium. Structure, functions and phylogeny of the complement system.
3/6/1991	University of Pennsylvania, Department of Pediatrics, Division of Infectious Diseases and Immunology. Evasion Strategies of Microorganisms.
10/23/1990	University of Pennsylvania, Department of Obstetrics and Gynecology. Molecular aspects of the C3 interactions with other complement components and complement receptors.
10/9/1990	University of Pennsylvania, Immunology Colloquium. Molecular aspects of the C3 interactions with other complement components and complement receptors.
9/27/1990	University of Pennsylvania, Department of Chemistry. Protein-protein interactions in the complement system.
2/3/1990	Institute for Tropical Diseases, Hamburg, Germany. Protein-protein interactions.
12/14/1989	Aristotelian University of Thessaloniki, Department of Pharmacology, Greece. Protein-protein interactions.
12/7/1989	University of Heidelberg, Institute of Immunology, Heidelberg, FRG. The multifunctional role of the third component of complement.
2/2/1989	University of Lausanne, Department of Biochemistry, Lausanne, Switzerland. Structure and functions of the third component of complement.
1/20/1989	University of Pennsylvania, Department of Pathology and Laboratory Medicine. The complement system as a model system to study protein-protein interactions.
3/24/1988	University of Innsbruck, Institute for Hygiene, Innsbruck, Austria. The multifunctional role of the third component of complement.
2/16/1988	Autoimmune Disease Center, Scripps Clinic and Research Foundation, La Jolla. Molecular aspects of the C3 interactions with complement receptors and other complement components.
2/11/1988	Molecular Biology Institute, SDSU, San Diego. Molecular aspects of the C3 interactions with complement receptors and other complement components.
2/2/1988	Institute Pasteur, Athens, Greece. The complement system as a model to study protein-protein interactions.
6/11/1987	Peptide synthesis Seminar ABI, Basel. Synthetic peptides: A tool to study protein-protein interactions.
6/5/1987	Institute of Molecular Biology, University of Madrid, Spain. The complement system: A model to study protein-protein interactions.
5/15/1987	International Titisee Conferences on Proteolytic processing and biological functions. Proteolytic processing of human C3 and its interactions with complement receptors.
4/28/1987	Institute Pasteur, Athens, Greece. The complement system.
1/29/1987	Institute of Clinical Immunology, Inselspital, University of Bern. The complement system.
12/17/1986	Department of Biology, Roche, Basel. Molecular interactions in the complement system.
9/19/1986	FEBS Summer School (Advanced course) on Immunological Methods and Applications, Göd, Hungary. Molecular interactions in the complement system.
5/30/1986	University of Texas at Houston, M. D. Anderson Hospital, Dept. of Immunology. The multifunctional role of the third component of complement.
12/9/1985	Aristotelian University of Thessaloniki, Department of Pharmacology, Greece. Molecular aspects of the C3 interaction with other complement components and complement receptors.
9/16/1985	Basel Institute for Immunology, Basel, Switzerland. Molecular aspects of the C3 interaction with other complement components and complement receptors.
8/27/1985	National Institutes of Health/Kidney Disease Section Seminar. Molecular aspects of the C3 interaction with other complement components and complement receptors.
4/9/1985	Immunology and Gesellschaft für Immunologie, Lake Balaton, Hungary. 4th Balaton Meeting on "Signals and signal processing in the immune system" Organized by The Hungarian Society for "Molecular aspects of the C3 interaction with CR2, CR3, Factor H and bovine conglutinin".
1/25/1985	Aristotelian University of Thessaloniki, Greece, Department of Biology. The use of monoclonal antibodies in Biomedical Sciences.
1/24/1985	Aristotelian University of Thessaloniki, Greece, Department of Biology. The complement system.
10/29/1984	Special workshop on complement receptors, Coconut Grove, Florida. Molecular aspects of the C3 interaction with complement receptors.
2/24/1984	University of Ioannina, Greece, Department of Medicine. Interaction of C35 fragments with complement receptors and regulatory proteins.
2/22/1984	University of Innsbruck, Institute for Hygiene, Innsbruck, Austria. Mapping of the properdin C5 and C3dR binding sites on the third component of complement.
2/21/1984	University of Heidelberg, Institute of Immunology, Heidelberg, FRG. Interaction of C3 fragments with complement receptors and regulatory proteins.
2/20/1984	Johannes-Gutenberg University Institute for Medical Microbiology, Mainz, FRG. Interaction of C3 fragments with complement receptors.
9/15/1981	Duke University Medical Center, Department of Medicine and Pathology. Complement Receptors.
7/13/1981	University of Lausanne, Department of Biochemistry, Lausanne, Switzerland. Isolation and characterization of three different complement receptors.